Background: Overweight or obesity is a prognostic factor for breast cancer recurrence and breast cancer-related deaths. However, weight control is difficult for breast cancer survivors because of menopause, chemotherapy, anti-hormonal therapy, and psychological issues….
Continue Reading
What You Should Know:
– Signos, a metabolic and weight management company, has announced the launch of the Signos Glucose Monitoring System.
– The system is the first FDA-cleared, over-the-counter glucose monitoring system for weight management….
Continue Reading
What You Should Know:
– Eli Lilly and Company has announced positive topline results from its Phase 3 ATTAIN-2 trial, which evaluated orforglipron, an investigational oral GLP-1 receptor agonist, in adults with obesity or overweight…
Continue Reading
Background: Overweight and obesity have become a public health issue. Lifestyle modifications delivered through mobile devices, especially mobile phones, present an opportunity to support weight loss efforts. However, evidence regarding the effects of mobile…
Continue Reading
Background: Obesity represents a major public health crisis in the United States, imposing substantial health risks and economic costs. Medical nutrition therapy (MNT) is an evidence-based treatment where a registered dietitian provides personalized nutrition…
Continue Reading
What You Should Know:
– Withings, a pioneer in connected health, announced findings from a groundbreaking analysis of body composition data, challenging the traditional reliance on Body Mass Index (BMI) for assessing obesity.
– The study…
Continue Reading
Form Health, a virtual obesity care provider, launched a new program on Tuesday to prevent the shift from overweight to obesity.
Boston-based Form Health already offers an obesity program for individuals with a body mass…
Continue Reading
